2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow DAC: new trials by email Literature Review of DAC trials Research Report on DAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations Arm A Mylotarg plus DA Versus CPX-351, Arm B Vosaroxin and Decitabine, Arm D Small molecule or Not - Acute Myeloid Leukaemia, Myelodysplastic Syndrome | Phase 2 / Phase 3 | Unknown | Cardiff University | 1600 | 2014-10-30 | 2020-01-23 |
| Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia DAC, CLAG, Consolidation, I HAM cycle - Acute Myeloid Leukemia | Phase 3 | Unknown | dr hab. n. med. Agnieszka Wierzbowska | 400 | 2014-02-01 | 2014-02-27 |
Leukemia, Myeloid, Acute (2) · Myelodysplastic Syndromes (1)
Cardiff University (1) · dr hab. n. med. Agnieszka Wierzbowska (1)
Denmark (1) · Poland (1) · United Kingdom (1)